Government proposals to ease clinical trial rules and what it means for R&D and innovation
New rules could boost innovation in clinical trials significantly.
Category: Pharmaceuticals & Healthcare Products
Pharmaceuticals & Healthcare Products
India’s dependence on imported APIs and strategies for boosting local manufacturing
India seeks to reduce reliance on imported APIs through local strategies.
Adoption of Indian Pharmacopoeia by international markets and its significance for trade
Indian Pharmacopoeia boosts global trade in pharmaceuticals.
How regulatory clarity in biologics approval can open new growth frontiers in Indian pharma
Regulatory clarity can boost India’s biologics sector significantly.
State-level pharma and medical device policies and their role in attracting investment
State policies shape the future of pharma investments significantly.
The impact of pharma-grade sugar export policies on domestic supply and global trade
Pharma-grade sugar policies reshape markets and trade dynamics.
Global companies setting up tech innovation centres in India and what it means for R&D
Global firms are boosting R&D by launching tech hubs in India.
Large acquisitions in Indian pharma and what consolidation means for competition and scale
Mergers in Indian pharma reshape competition and market dynamics.
Pharma exporters seeking rollback of export bans on India-only drugs and its policy implications
Pharma exporters push to lift bans on India-only drug exports.
The future of Indian obesity drug pipelines and the global race to develop novel molecules
India’s obesity drug pipeline is vital for global health innovation.